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ABSTRACT OF DISSERTATION 
 
COMPUTATIONAL INVESTIGATION OF TRANSMURAL DIFFERENCES IN 
LEFT VENTRICULAR CONTRACTILITY AND HYDROGEL INJECTION 
TREATMENT FOR MYOCARDIAL INFARCTION 
 
Heart failure (HF) is one of the leading causes of death and impacts millions 
of people throughout the world. Recently, injectable hydrogels have been 
developed as a potential new therapy to treat myocardium infarction (MI). This 
dissertation is focused on two main topics: 1) to gain a better understanding the 
transmural contractility in the healthy left ventricle (LV) wall and 2) investigate the 
efficacy of the hydrogel injection treatment on LV wall stress and function. The 
results indicate that a non-uniform distribution of myocardial contractility in the LV 
wall provide a better representation of normal LV function. The other important 
study explored the influence altering the stiffness of the biomaterial hydrogel 
injections. These results show that a larger volume and higher stiffness injection 
reduce myofiber stress the most and maintaining the wall thickness during loading. 
The computational approach developed in this dissertation could be used in the 
future to evaluate the optimal properties of the hydrogel. The last study used a 
combination of MRI, catheterization, finite element (FE) modeling to investigate the 
effects of hydrogel injection on borderzone (BZ) contractility after MI. The results 
indicate that the treatment with hydrogel injection significantly improved BZ 
function and reduce LV remodeling, via altered MI properties. Additionally, the wall 
thickness in the infarct and BZ regions were significantly higher in the treated case. 
Conclusion: hydrogel injection could be a valuable clinical therapy for treating MI.  
KEYWORDS: Finite element modeling, Hydrogel injection, Myocardial infarction, 
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1 
 INTRODUCTION 
 
1.1 Motiviation  
Cardiovascular disease remains a leading cause of morbidity and mortality 
worldwide. According to the 2016 American Heart Association Statistics, more than 
17.3 million people die each year and is number is projected to increase to more 
than 23.6 million by 2030 [1]. Several mechanisms that lead to systolic heart failure 
(HF) include atherosclerosis, hypertension, myocardial infarction and mitral 
regurgitation. This dissertation is focused on the effects of myocardial infarction. 
According to the report statistic, roughly 785,000 people in the United States have 
a myocardial infarction each year, which can eventually lead to chronic heart failure 
[1]. An estimated 82.6 million American adults (>1 in 3) have 1 or more types of 
cardiovascular disease. In the state of Kentucky, more than 40% of adults have 
multiple risk factors. In terms of economic impact, the total cost due to 
cardiovascular disease exceeded $286 billion.  
Since heart failure is a significant medical burden to the developed world, 
there is a need for better solutions to solve this problem. In order to address the 
issue of myocardial infarction, biomaterial injections have recently been proposed 
as a potential new therapy for augmenting ventricular mechanics after myocardial 
infarction. This approach could reduce the stress in the failing ventricular wall and 
act to retard the progression of heart failure. In order to better understand the 
mechanical effects of this treatment, new methods that combine magnetic 
resonance imaging (MRI), catheterization and finite element (FE) modeling are 
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being used to investigate hearts that are healthy, diseased and/or treated. This 
method could be used to observe how the stress changed in the ventricular wall. 
Since myocardial contractility of the left ventricle wall plays an essential role in 
maintaining normal pump function, it is important to have proper parameters to 
describe left ventricular behavior when analyzing contractility with numerical 
simulation. Additionally, the efficacy of using biomaterial injections, which could be 
used to treat myocardial infarction, has motivated the use of computational 
methods to investigate the stress reduction in different regions after myocardial 
infarction.  
 
1.2 Background on structure and function 
The heart is an integral part of the cardiovascular system and is composed 
of four primary chambers: right atrium, right ventricle, left atrium and left ventricle. 
The left ventricle (LV) is the strongest chamber among these four chambers and 
pumps oxygen-rich blood to the rest the body. This dissertation is focusing on the 
LV as it can be significantly affected by cardiovascular disease.  The left ventricular 
wall consists of three layers, epicardium, myocardium and endocardium. 
Myocardial contractility depends on several factors, including action potential 
morphology, Ca+ dynamics, and sarcomere length (Figure 1) [2]. It has been 
shown in previous studies that these factors vary as a function of transmural 
location in the LV wall [3, 4]. Also, some ex-vivo experimental studies have 
examined the difference in isometric force generation in permeabilized 
cardiomyocytes, but only in samples from the sub-epicardium and sub-
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endocardium of the LV [5, 6]. However, a recent study examined cardiomyocyte 
samples from all three transmural regions and showed that maximum isometric 
force generation exhibits transmural heterogeneity in healthy human hearts with 
the mid-myocardium generating greater force than the sub-endocardium and sub-
epicardium [7]. However, there is no computational results which report that 
myocardial force generation varies transmurally. Better understanding the 
contractility in the LV wall will be explained in chapter 3.   
The distribution of stress in the LV wall is impacted by both the fiber tension 
and fiber orientation. In 1969, the paper by Streeter et al. [8] indicated that the 
myocardial wall has a well-ordered distribution of fiber angle ranged from -60° to 
60° (from epicardium to endocardium) in normal canine heart. Besides this, in 
comparison to normal heart, the fiber angles changed in pressure-overload heart. 
As mentioned in Carew et al. [9], the fiber angle was tested between -67.5° and -
90° in endocardium and ranged from 67.5° to 90° in epicardium. The method used 
to study the fiber orientations was described in the paper [8, 9].  
The normal healthy left ventricle has a thick muscular wall, which is shown 
in Figure 2(A). The healthy heart pumps blood through the network of arteries and 
veins, which is important for maintaining normal bodily function. However, after 
myocardial infarction (MI), a coronary artery is suddenly blocked, and cardiac 
tissue in the LV wall is deprived of oxygen and part of the heart muscle dies. Over 
time this can lead to ischemia and arrhythmias, which cause a severe decrease in 
the pumping function of the heart. Figure 2 shows the tissue structure changes 
after myocardial infarction. Eventually, during remodeling, due to an overload 
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blood flow and pressure in LV, the LV wall can overstretch and become thinner 
(Figure 2(B) and Figure 2(C)).   
 The pathology of MI can be considered as four phases: acute ischemia, the 
necrotic phase, the fibrotic phase and the remodeling phase. In the first few hours, 
this is called acute ischemia. It occurs just after infarction; the myocardium loses 
the ability to generate systolic force [10]. Then the ischemic myocardium behaves 
as a passive elastic material during the whole cardiac cycle. [10]. The first phase 
was also described in 1978 by Hutchins and Bulkley, has been termed “infarct 
expansion” and defined as “acute dilatation and thinning of the area of infarction 
not explained by additional myocardial necrosis” [11]. As a result in this phase, the 
mechanics of the infarcted myocardium changed from active material to passive 
material [10]. The second phase is called necrotic phase, and usually lasts about 
7 days in human and 5 days in rat [12]. The stiffness of the infarct region was 
increased during this phase [10]. There are two changes in mechanics in this 
phase. First is that, the stiffness in circumferential and longitudinal direction is 
increased under multiaxial loading but there is no apparent change in uniaxial 
loading [10]. The second is that, at least in circumferential direction, unstressed 
segment length increases whereas end-diastolic length not [10]. The third phase 
is fibrotic phase. The stiffness of the infarct region is increased and the left ventricle 
cannot be expand fully due to the malfunction of diastolic filling, which limit the 
pump function of the heart [10]. During the fourth phase, which is called remodeling 
phase, the stiffness of infarct tissue is decreased while the stiffness in 
circumferential direction remains nearly twice that of the longitudinal direction.  
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The myocardial infarction may affect the infarcted regions and non-infarcted 
regions. The remodeling process will influence the function of the left ventricle and 
prognosis for survival. Early infarct expansion or stretching has been associated 
with poor long-term prognosis [13-15] and has been identified as the mechanical 
phenomenon that initiates and sustains the process of adverse post-MI LV 
remodeling that leads to heart failure [16-21]. Infarct expansion causes abnormal 
stress distribution in myocardial regions within and outside the MI, especially in the 
adjacent normally perfused borderzone (BZ) region. With time, increased regional 
stress is the stimulus for maladaptive biologic processes, such as matrix 
metalloproteinase activation, that inherently alter the contractile properties of 
normally perfused myocardium [22]. Once initiated, these maladaptive processes 
lead to a heart failure phenotype that is difficult to reverse by medical or surgical 
means. Observing the contractility in borderzone region, infarct region and remote 
region is a way to better understand the remodeling process so that treatment can 
be improved after MI. LV remodeling is a pathological adaptive process due to 
myocardial infarction (Figure 3). After the initial insult, infarct expansion and 
ventricular wall thinning, it contributes to further ventricular remodeling. During the 
ventricular remodeling process, pressure and radius increase in the LV, and LV 
free wall thins (Figure 4). This process will increase the cardiac wall stress. 
 
1.3 Overview  
The overall goal of this dissertation work is to generate a better FE model 
of the LV. This was done by investigating normal myocardial function and then 
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examining the effects of biomaterial injections as a treatment for altering MI 
mechanics. This work was accomplished using a combination of finite element (FE) 
modeling, magnetic resonance imaging (MRI) and ventricular pressure 
catheterization to assess in vivo myocardial material properties in the LV using 
numerical optimization.  
Chapter 2 outlines the constitutive behavior of myocardium (in passive 
response and active contraction) and hydrogel injections. Chapter 3 is to estimate 
the in-vivo contractile forces generated in the sub-endocardial, mid-myocardial, 
and sub-epicardial regions of healthy porcine ventricles. This work was motivated 
by recent ex-vivo transmural measurements [7]. In Chapter 4 and Chapter 5, I will 
focus on a therapy using injectable biomaterials to attenuate left ventricular 
remodeling after myocardial infarction. Specifically, Chapter 4 discusses a 
numerical sensitivity study of hydrogel injection motived by work done using two 
different hydrogels to treat myocardial infarction. Chapter 5 investigates the effects 
of hydrogel injection on borderzone contractility after myocardial infarction. The 
relevant literature review is detailed in each Chapter. 
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Figure 1 Myofiber systolic contraction depends on calcium concentration (A) 
and sarcomere length (B) [2] . 
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Figure 2 A normal left ventricle wall. B left ventricle wall after myocardial 
infarction. C Finally causing the ventricle wall to become thinner [23]. 
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Figure 3 Myocardial Wall thickness for normal tissue (remote region) and MI 
tissue [24].  
 
Figure 4 Ventricular remodeling after acute infarction [1].  
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 Constitutive behavior 
 
The material response of the myocardium was represented using a nearly 
incompressible, transversely isotopic, hyperelastic constitutive law, which was 
defined using the following strain energy function: 
𝑊𝑚𝑦𝑜𝑐𝑎𝑟𝑑𝑖𝑢𝑚 =  
𝐶
2
(𝑒𝑏𝑓𝐸𝑓𝑓
2 +𝑏𝑡(𝐸𝑠𝑠
2 +𝐸𝑛𝑛
2 +𝐸𝑛𝑠
2 +𝐸𝑠𝑛
2 )+𝑏𝑓𝑠(𝐸𝑓𝑠
2 +𝐸𝑠𝑓
2 +𝐸𝑓𝑛
2 +𝐸𝑛𝑓
2 ) − 1) +  
𝜅
2
(𝐽 − 1)2   
(Eq. 1) 
where 𝐸𝑖𝑗
  are the deviatoric components of the Green-Lagrange strain tensor 
(defined in Eq. 2a) relative to the myofiber coordinate system (f = fiber direction, s 
= cross-fiber in-plane direction, n = transverse-fiber direction) and J is the 
determinant of the deformation gradient (Eq. 2b).  
 𝑬 =
1
2
(𝑭𝑻𝑭 − 𝑰)                                                                                           (Eq. 2a) 
 𝐽 = det (𝑭)                                                                                                  (Eq. 2b) 
Where 𝑭 is the deformation gradient, 𝑭𝑻𝑭 describe the Cauchy-Green deformation 
tensor and 𝑰 is the identity tensor. The 𝐶, 𝑏𝑓, 𝑏𝑡, and 𝑏𝑓𝑠  are the diastolic material 
parameters; where 𝐶 scales stress in all directions, 𝑏𝑓 affects the fiber direction 
stiffness, 𝑏𝑡  affects cross-fiber direction stiffness, and 𝑏𝑓𝑠  is transverse-fiber 
direction stiffness. The material response of the hydrogel injections was 
represented using a nearly incompressible, isotopic, hyperelastic constitutive law, 
which was defined using the following strain energy function: 
𝑊𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 =  
𝐸
2(1+𝜈)
 tr(𝐄𝟐)  + 
𝐸
6(1−2𝜈)
 ln (𝐽)2                           (Eq. 3) 
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where E is the deviatoric Green-Lagrange strain tensor, tr( ) is the trace operator, 
and ln( ) is the natural log operator. The material parameters for Young’s modulus 
(E) were assigned based on the experimental measurements of the hydrogels, 
while the Poison ratio (𝜈) was assigned a value of 0.499.  
Systolic stress was modeled as the sum of the passive stress derived from 
the strain energy function and an active fiber directional stress component T0 [2, 
25], which was defined by a function of time, 𝑡,  peak intracellular calcium 
contraction, 𝐶𝑎0, sarcomere length, 𝑙, and maximum isometric tension achieved at 
the longest sarcomere length 𝑇𝑚𝑎𝑥 [26].  
𝐒 =  𝑝𝐽𝐂−1 + 2𝐽−
2
3𝐷𝑒𝑣 (
𝜕?̃?
𝜕?̃?
) + 𝐓𝟎{𝑡, 𝐶𝑎0, 𝑙, 𝑇𝑚𝑎𝑥}                                             (Eq. 4) 
where 𝐷𝑒𝑣() is the deviatoric operator.  
𝐓0 =  
1
2
𝑇𝑚𝑎𝑥
𝐶𝑎0
2
𝐶𝑎0
2+𝐸𝐶𝑎50
2 (1 − cos(
0.25
𝑚𝑙𝑅√2𝐸11+1+𝑏
+ 1)𝜋)                                        (Eq. 5) 
where m and b are constants, E11 is strain in the fiber direction, Ca0 is peak 
intracellular calcium concentration, 𝑇𝑚𝑎𝑥 is maximum isometric tension achieved 
under maximal activation, and 𝐸𝐶𝑎50
2  is the length-dependent calcium sensitivity 
given by,  
𝐸𝐶𝑎50
2 =
(𝐶𝑎0)𝑚𝑎𝑥
√𝑒𝑥𝑝[𝐵(𝑙𝑅√2𝐸11+1−𝑙0)]−1
                                                                       (Eq. 6) 
where B is a constant, (𝐶𝑎0)𝑚𝑎𝑥  is maximum peak intracellular calcium 
concentration, 𝑙0 is the sarcomere length at which no active tension develops, and 
𝑙𝑅 is the stress-free reference  sarcomere length. The parameters Tmax and 𝑙𝑅 are 
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discussed further in the next section. However, all other material properties used 
for active myocardium are defined in [25]. 
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 Transmural differences in left ventricular contractility 
 
3.1 Introduction  
Several myocardial contractility properties have been shown to vary as a 
function of LV location. Experimental ex-vivo studies have examined action 
potential morphology, Ca2+ dynamics, sarcomere length, and isometric force 
generation [2] [5-7, 27, 28]. In addition to cellular experiments, finite element (FE) 
modeling has been used, in combination with magnetic resonance imaging (MRI) 
and ventricular pressure catheterization, to assess in-vivo myocardial material 
properties in the LV. In these studies, numerical optimization was used to minimize 
the difference between the deformation field calculated from MRI and that 
predicted by the FE model, using the measured pressure as a boundary condition. 
Passive material parameters have been estimated in the LV for both healthy [29, 
30] and infarcted myocardium [31, 32]. The maximum contractile force that can be 
generated within the remote and border zone regions of LVs with myocardial 
infarction was also assessed using this approach [33-35]. However, transmural 
variations in force generation were not examined in these studies. 
The goal of the current study, therefore, was to estimate the in-vivo 
contractile forces generated in the sub-endocardial, mid-myocardial, and sub-
epicardial regions of healthy porcine ventricles. This was accomplished by using a 
combination of MRI, catheterization, and FE modeling. Properties were 
determined by using an optimization scheme to minimize the difference between 
in-vivo strains and ventricular volume calculated from MRI and FE model predicted 
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strains and volume. This work was motivated by recent ex-vivo transmural 
measurements [7]. 
 
3.2 Method  
3.2.1 Experimental measurements 
The animals used in this work received care in compliance with the 
protocols approved by the Institutional Animal Care and Use Committee at the 
University of Pennsylvania in accordance with the guidelines for humane care 
(National Institutes of Health Publication 85-23, revised 1996). In order to assess 
regional wall deformation in healthy adult pigs (n=4; male; approximately 40 kg), 
3D SPAMM (SPAtial Modulation of Magnetization) MRI was performed with 
simultaneous LV pressure measurements using a pressure transducer (Millar 
Instruments, Houston, TX) [32]. The endocardium and epicardium of the LV were 
contoured from the MR images at early-diastolic filling, end-diastole, and end-
systole in order to generate the reference geometry and calculate LV cavity volume. 
In-vivo systolic strain was calculated using a custom optical flow plug-in for ImageJ 
to derive 3D displacement flow fields [36].  
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3.2.2 FE model 
Each animal-specific LV FE mesh (n=4) was produced using tri-linear 
hexahedral brick elements (TrueGrid; XYZ Scientific, Inc., Livermore, CA). A 
myofiber distribution of -37o (at epicardium) to +83o (at endocardium), with respect 
to the circumferential direction, was used [37]. The LV wall was evenly divided into 
three layers: sub-epicardium, mid-myocardium, and sub-endocardium (Figure 5). 
The measured pressure was used as a boundary condition to simulate end-
diastole and end-systole.  
The material behavior for passive myocardium was considered as 
hyperelastic, nearly incompressible, and transversely isotropic with respect to the 
local myofiber direction. The strain energy function is defined in Eq. 1. The diastolic 
material parameters were determined in a previous study for each animal and 
incorporated into the animal-specific FE models [32]. Systolic stress was modeled 
as the sum of the passive stress derived from the strain energy function and an 
active fiber directional stress component T0 (Eq. 3) [2, 25]. Note the one of the key 
parameters used to describe active stress is Tmax, which represents the maximum 
isometric force that can be generated by a myocyte. Each FE simulation was 
conducted in two phases, where the first phase represented passive diastolic filling 
and the second phase represented active systolic contraction to end-systole (LS-
DYNA, Livermore Software Technology Corporation, Livermore, CA). 
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3.3 Optimization procedure 
The primary focus of the optimization was to determine the distribution of 
Tmax within the LV wall. The optimization process was performed using the software 
LS-OPT (Livermore Software Technology Corporation, Livermore, CA) as 
previously described [31]. Briefly, the genetic algorithm (GA) technique was used 
to minimize the objective function, which was taken to be the mean squared error 
(MSE) between experimentally measured data and FE predicted results, and was 
defined as 
𝑀𝑆𝐸 = ∑ ∑ (𝐸𝑖𝑗,𝑛 − ?̅?𝑖𝑗,𝑛)
2
𝑖,𝑗=1,2,3
𝑁
𝑛=1 + (
𝑉−?̅?
?̅?
)
2
                                                     (Eq. 6) 
 
where 𝑛 is the strain point within the myocardium, 𝑁 is the total number of strain 
points, 𝐸𝑖𝑗,𝑛 and 𝑉 are the FE predicted end-systolic strain and LV cavity volume, 
respectively (over bar variables represent in-vivo measured values). A total of 
N=756 points evenly distributed throughout the FE model were compared to the 
nearest LV points from the MRI-derived strain data. Specifically, the points were 
selected at the element centroids in a pattern of 3 transmural x 36 circumferential 
x 7 longitudinal points. Over the LV wall, this yielded 252 points per transmural 
layer. The search range for the parameter Tmax was 40 kPa to 400 kPa based on 
previous studies [33, 34, 38, 39]. In order to determine the transmural distribution 
of Tmax, in combination with different transmural distributions of 𝑙𝑅, four cases were 
tested with the aforementioned optimization procedure (Table 1). Once each 
optimization was fully converged, the 95% confidence intervals were calculated for 
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the last iteration of each case. The intervals were based on the parameters used 
to generate the 64 simulations that were run during the last iteration and represent 
the range over which the optimization is 95% confident that the parameter values 
exist. 
 
3.4 Results  
All of the optimizations converged to the final set of Tmax parameters after 
15 generations of the GA. The values of Tmax optimized for each case are shown 
in Tables 2-5 along with their respective 95% confidence intervals. Notably, as 
compared to Case 1 (Table 2) where both 𝑙𝑅 and Tmax were uniformly distributed, 
inclusion of transmural variations in either 𝑙𝑅 (Case 2; Table 3) or Tmax (Case 4; 
Table 5) led to a smaller MSE value in all four animals; the MSE values decreased 
by 13% and 15% in Case 2 and Case 4, respectively, on average. Inclusion of 
transmural variations in both 𝑙𝑅  and Tmax as in Case 3 further decreased the 
averaged MSE value by 22% as compared to Case 1 (Table 2 vs. Table 4). 
Interestingly, in both Case 3 and Case 4, most of the animals (3 out of 4) exhibited 
higher Tmax in the mid-myocardium as compared to the values in the sub-
epicardium and sub-endocardium (Tables 4 and 5, Figures 6 and 7). On average, 
Tmax  generated in the mid-myocardium was more than 1.7 times of that produced 
in the other layers in these two cases.   
The transmural distribution of systolic strain components (circumferential, 
longitudinal, and circumferential-longitudinal shear) in the LV free wall was 
investigated more closely for Case 1 and Case 3, which exhibited the highest and 
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lowest MSE value, respectively. Both Case 1 and Case 3 exhibited a non-uniform 
distribution of systolic strain similar to the experimental data (Figure 8). Moreover, 
the sub-endocardium consistently exhibited the largest magnitude of systolic strain. 
Results of Case 3, however, showed better agreement with the experiment 
measurements as compared to those of Case 1. Specifically, the systolic strain 
distribution from Case 3 was within the 95% confidence interval of the 
experimentally measured strain components, whereas Case 1 fell outside of the 
intervals (Figure 8). The value of the objective function was also assessed within 
each transmural layer for Case 1 and Case 3. The value of MSE in the sub-
epicardium, mid-myocardium, and sub-endocardium was 17.33, 14.45, 36.83 for 
Case 1, respectively, and 16.5, 13.3, 23.6 for Case 3, respectively. The fit between 
the experimental and FE calculated results was improved in all three transmural 
layers for Case 3. Most notably, the value of  MSE was decreased by 35% in the 
sub-endocardial layer, which showed the most improvement in the fit.   
In order to assess the influence of non-uniform contractility and reference 
sarcomere length on LV torsion, the twist angle at the apex of the FE models was 
calculated in each of the 4 cases (Figure 9).  These calculations were performed 
using the approach outlined in [19]. The results indicate that Case 3 produced the 
largest twist angle, compared to the other cases. More specifically, when 
comparing Case 2 and Case 3, which have the same non-uniform distribution of 
𝑙𝑅 but different distributions of Tmax, it can be seen that a uniform distribution of 
Tmax  produced a twist angle of 11.5 degrees (Case 2) compared to a non-uniform 
distribution, which produced a twist angle of 16.3 degrees (Case 3). Interestingly, 
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when comparing Case 4 and Case 3, which both have non-uniform distributions of 
Tmax but different distributions of 𝑙𝑅, it can be seen that a uniform distribution of 𝑙𝑅  
produced a twist angle of 12.2 degrees (Case 4). This implies that the distribution 
of Tmax has more of an effect on the twist angle than the distribution of 𝑙𝑅. When 
both Tmax  and 𝑙𝑅 were assumed to be uniform (Case 1), LV twist angle was at a 
minimum with a value of only 9 degrees.  
 
3.5 Discussion  
The goal of the current study was to estimate the transmural distribution of 
in-vivo myocardial contractile force using a combination of MRI, catheterization, 
FE modeling, and numerical optimization. For this purpose, the maximum isometric 
tension, Tmax, was investigated particularly because it is one important determinant 
of cardiomyocyte contractility. A recent ex-vivo study has shown that maximum 
isometric force generation exhibits transmural heterogeneity in healthy human 
hearts [7]. Consistent with these results, the current study showed that when the 
same level of Tmax is used in all three transmural regions, the MSE values are much 
larger than those with a non-uniform distribution. This indicates that the strain field 
in a model with non-uniform contractility distribution is more representative of the 
deformation that occurs in-vivo. In support of this, the model with transmural 
variations in Tmax exhibited better agreement with the in-vivo experimental 
measures in terms of systolic strains. Recently, a sensitivity study was performed, 
which evaluated the influence of different transmural distributions of contractile 
force, and showed that the transmural distribution affects LV deformation via 
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altered torsion [40]. This may, at least in part, explain the better fit exhibited by 
models assuming a non-uniform contractility distribution across the LV wall. 
Moreover, in the current study the fit was further improved by incorporating a non-
uniform transmural distribution of the reference sarcomere length, which 
represents a more realistic morphology of the LV. 
Interestingly, with this more representative FE model of the LV, the mid-
myocardium from most of the animals tested in the current study exhibited the 
highest contractile force, which was followed by the sub-epicardium and sub-
endocardium, in terms of Tmax. Although these results were not associated with 
statistical significance, they show strong agreement with the recent ex-vivo 
experimental results of [7].  In addition, previous studies have reported that the 
epicardium contracts slightly more than the endocardium, which is consistent with 
our study results [5, 6]. Finally, consistent with previous studies [41-43], the systolic 
strain components exhibited transmural variation, where the highest magnitude 
occurred at the endocardial surface and the lowest at the epicardial surface. 
In order to more directly assess changes in LV torsion, the apical twist angle 
was measured in each of the models. It was found that a non-uniform distribution 
of Tmax produced the largest value of twist angle compared to the cases with a 
uniform distribution. This implies that transmurally varying contractile properties 
could be a key factor in maximizing LV torsion. Although residual stress was not 
included in the model, the non-uniform transmural distribution of the reference 
sarcomere length incorporates an important factor that influences systolic function. 
This, together with transmurally varying contractility, may serve to homogenize the 
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force generation during LV systole for an optimal pump function.  In addition, 
changes in the magnitude of the active stress in the cross-fiber direction also 
impacted the fitness of FE models to experimental data (data not shown). Again, 
in these cases, models assuming transmurally varying Tmax and 𝑙𝑅 provided the 
best fit.  
It should be noted that the contribution of the relative volume change to the 
MSE calculation was much less than the contribution of the strain. In all of the 
cases, the LV volume in the model was within 5% of the experimentally measured 
value. This implies that all the converged models matched the end-systolic volume 
very closely. Therefore, when comparing the MSE values of all the cases, the 
differences are primarily attributed to the model fit to the experimental strain. For 
example, comparing the average MSE for Case 1 (68.65) to that of Case 3 (53.47) 
implies that the decrease in MSE is caused by a better fit to the experimental strain 
data when using a heterogeneous sarcomere length and isometric tension 
distribution. 
The model-predicted longitudinal strain showed greater shortening than the 
experimental strain, whereas the circumferential strain showed less shortening 
than the experimental strain. This effect in the model could explain the discrepancy 
between the model cases and the experimental strain (Figure 8). This result could 
be affected by the fiber angle distribution, which was based on histology rather 
than diffusion tensor MRI data (since it was not available), the assumption of 
transverse isotropy, or the level of cross-fiber contraction. These limitations will be 
addressed in future studies.  
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3.6 Conclusion 
In conclusion, the current study showed that a non-uniform transmural 
distribution of myocardial contractile force produced the best agreement between 
in-vivo measured strain from MRI and that predicted by the FE model. More 
experiments are needed to confirm the in-vivo results of the current study. Despite 
the limited statistical power due to the small sample size (n=4), the results support 
recent experimental ex-vivo measurements on cardiomyocytes [7], which showed 
that the mid-myocardium generates the greatest force. Since heart disease has 
recently been associated with altered myocardial contractility in specific transmural 
regions [7], the incorporation of transmural variation of active properties, therefore, 
may provide a better representation of how disease alters LV function. 
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Table 1 Description of 4 cases used in the optimization of transmural 
contractility. 
Cases  
 
Description 
 
Case 1 
𝑙𝑅 was assigned as 1.85 µm in all three myocardial layers, and Tmax 
assumed the same value throughout the LV wall during optimization 
Case 2 
𝑙𝑅 was assigned as 1.91 µm, 1.85 µm, and 1.78 µm in the sub-epi-, 
mid-, and sub-endo-myocardium, respectively, and Tmax assumed the 
same value throughout the LV wall during optimization 
Case 3 
𝑙𝑅 was assigned as 1.91 µm, 1.85 µm, and 1.78 µm in the sub-epi-, 
mid-, and sub-endo-myocardium, respectively, and Tmax was allowed 
to vary in all three LV layers during optimization 
Case 4 
𝑙𝑅 was assigned as 1.85 µm in all three myocardial layers, and Tmax 
was allowed to vary in all three LV layers during optimization 
Note: Transmural distributions of reference sarcomere lengths are based on 
measurements of unloaded rat LV taken from [44]. 
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Table 2 Transmural distribution of maximum isometric tension (Tmax; kPa) 
in Case 1. 
Animal 
Maximum isometric tension ± 95% confidence interval 
MSE 
sub-epicardium mid-myocardium sub-endocardium 
1 84.93 ± 4.30 84.93 ± 4.30 84.93 ± 4.30 89.33 
2 97.13 ± 4.83 97.13 ± 4.83 97.13 ± 4.83 66.34 
3 76.45 ± 3.51 76.45 ± 3.51 76.45 ± 3.51 57.70 
4 182.00 ± 10.66 182.00 ± 10.66 182.00 ± 10.66 61.21 
Mean 110.13 68.65 
Note: Case 1: uniformly distributed reference sarcomere length across the LV 
wall. 
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Table 3 Transmural distribution of maximum isometric tension (Tmax; kPa) 
in Case 2. 
Animal 
Maximum isometric tension ± 95% confidence interval 
MSE 
sub-epicardium mid-myocardium sub-endocardium 
1 80.13 ± 3.18 80.13 ± 3.18 80.13 ± 3.18 65.45 
2 97.05 ± 4.93 97.05 ± 4.93 97.05 ± 4.93 63.65 
3 75.17 ± 3.03 75.17 ± 3.03 75.17 ± 3.03 52.20 
4 169.30 ± 8.63 169.30 ± 8.63 169.30 ± 8.63 57.20 
Mean 105.41 59.60 
Note: Case 2: transmurally varying reference sarcomere length. 
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Table 4 Transmural distribution of maximum isometric tension (Tmax; kPa) 
in Case 3. 
Animal 
Maximum isometric tension ± 95% confidence interval 
MSE 
sub-epicardium mid-myocardium sub-endocardium 
1 118.10 ± 3.63 63.08 ± 2.18 60.88 ± 2.45 51.61 
2 86.48 ± 3.49 140.80 ± 5.36 51.22 ± 2.14 60.49 
3 76.17 ± 3.31 83.92 ± 3.87 51.10 ± 2.55 48.00 
4 148.10 ± 4.83 254.30 ± 6.32 72.72 ± 3.76 53.78 
Mean 107.21 135.53 58.98 53.47 
Note: Case 3: transmurally varying reference sarcomere length. 
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Table 5 Transmural distribution of maximum isometric tension (Tmax; kPa) 
in Case 4. 
Animal 
Maximum isometric tension ± 95% confidence interval 
MSE 
sub-epicardium mid-myocardium sub-endocardium 
1 102.70 ± 4.55 78.80 ± 3.14 50.02 ± 1.96 61.49 
2 50.08 ± 2.25 199.0 ± 6.53 102.40 ± 3.32 62.56 
3 79.24 ± 3.25 90.93 ± 4.19 50.29 ± 3.41 53.28 
4 173.50 ± 5.08 290.10 ± 7.65 81.60 ± 3.93 56.77 
Mean 101.38 164.71 71.08 58.50 
Note: Case 4: uniformly distributed reference sarcomere length across the LV 
wall. 
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Figure 5 Representative animal-specific FE model of a porcine LV with 3 
transmural layers. (a) 3D view; (b) short axis view; (c) long axis view. 
a 
b 
c 
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Figure 6 Visual representation of transmural distribution of maximum 
isometric tension in Case 3.  
 
Figure 7 Visual representation of transmural distribution of maximum 
isometric tension in Case.  
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Figure 8 Transmural distribution of (a) circumferential, (b) longitudinal, and 
(c) circumferential-longitudinal strain at end-systole in the LV free wall. Case 
1: uniformly distributed reference sarcomere length and maximum isometric 
tension; Case 3: transmural varying reference sarcomere length and 
maximum isometric tension.  
c 
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Figure 9 Apex twist angle (degrees) calculated in the FE models for each of 
the cases. Values were mean ± SEM; n = 4 animals. 
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 Sensitivity study of hydrogel injection characteristics for 
myocardial support 
 
This study is a continuation of previous work done in collaboration with the 
University of Pennsylvania, which sought to evaluate the efficacy of two different 
hydrogels for treating myocardial infarction in ovine infarct heart and explores the 
fact that the stiffness of these injections can be tuned to minimize wall thinning and 
ventricular dilation [24].  
 
4.1 Introduction  
The material properties of myocardium are an important determinant of global 
LV function in both health and disease. One potential treatment strategy being 
investigated is the use of biocompatible injectable materials as a means of 
augmenting MI mechanics. Several formulations of injectable biomaterials have 
been studied using animal models to evaluate the impact on wall thickness and 
global LV function [45-48]. These in vivo studies have demonstrated that injectable 
hydrogel injections can mitigate the adverse effects of MI [24, 48].  
Interestingly, the stiffness of these injections can be tuned to minimize wall 
thinning and ventricular dilation. Specifically, work done by Rodell et al. tested two 
different hydrogel injections with altered stiffness characteristics, namely, one with 
a higher stiffness (41 kPa) called dual-crossing (DC) and another with a lower 
stiffness (0.8 kPa) called gust-host (GH) [24]. This study aims to evaluate the 
efficacy of these two different hydrogels for treating myocardial infarction in ovine 
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heart, compared to control injection case. There are three separate groups: MI 
control with saline injection, MI treatment with soft hydrogel, MI treatment with 
stiffening hydrogel used in this study. The study is summarized below. 
The LV myofiber stress distribution around the GH and DC hydrogel injections 
is shown in Figure 10A and 10B, along with the transmural distribution of stress 
between injections (Figure 10C). The DC hydrogel reduced the myofiber stress by 
roughly 36% at the epicardium, 14% at mid-myocardium, and 43% at endocardium 
compared to the control case (Figure 10C) [24]. However, the GH hydrogel case 
showed almost no change in the transmural distribution of myofiber stress 
compared to the control case. Additionally, the average myofiber stress in the 
myocardium surrounding the DC injection was 2.5 kPa (26% reduction compared 
to control) and the stress around the GH injection was 3.4 kPa (0% reduction 
compared to control) [24]. This is primarily driven by the fact that the DC injections 
maintained their original shape (due to material stiffness), which allowed the LV 
wall to remain thick (Figure 10B). However, it can be seen that the GH injections 
effectively collapse as the LV wall is loaded by the pressure on the endocardium 
(Figure 10A). More specifically, the average wall thickness at end-diastole for the 
control case was approximately 1 cm, while the thickness for the GH case was 
1.08 cm and the DC case was 1.23 cm [24]. 
The results showed a better ability to limit infarct expansion and remodeling 
with the higher stiffness hydrogel injection. Inspired by that study, the current 
investigation combines experimental data and finite element (FE) modeling to 
better understand how hydrogel injection stiffness and volume influence 
 
35 
myocardial wall stress and wall thickness. This was accomplished by using 
previously measured MRI data from explanted ovine LVs, which were injected with 
an array of hydrogel, in order to assess injection geometry. FE models were then 
constructed to represent various combinations of injection volume within the LV 
wall, over a range of hydrogel elastic moduli. 
 
4.2 Method  
4.2.1 Finite Element Model 
In order to evaluate the effects of various hydrogels, FE models of the LV with 
two different injection volumes (150 µL and 300 µL) were generated, as well as a 
control model with no injections. The reference configuration of each model was 
chosen to represent early diastole, since the stress in the LV is at a minimum. The 
LV FE meshes were produced using tri-linear hexahedral brick elements (TrueGrid; 
XYZ Scientific, Inc., Livemore, CA). The size and shape of the hydrogel injections 
were based on MRI reconstruction of injected explant tissue (Figure 11 12, Table 
7) [24, 49]. The geometry of the LV wall was based on experimental measurements 
from the ovine hearts [24]. For the control case, the undeformed wall thickness 
was approximately 1.3cm, the inner diameter of the endocardial wall near the 
equator was 4 cm, and the distance from base to apex was 6.4 cm.  
For the models with hydrogel injections, the control model was modified to 
include a 4 x 4 pattern of 16 injections within the myocardium and the spacing 
between injections was assumed to be 1.5 cm from center to center (Figure 13a) 
[24, 49, 50]. Since the injections remain as discrete plugs in the LV wall, rather 
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than diffusing into the tissue, the total volume of myocardium must be conserved. 
This was accomplished by increasing the wall thickness in the injection region 
within each FE model. For the case of 300 µL injections, the wall thickness was 
increased by 1.5 mm to account for the volume added to the wall (Figure 13b). For 
the case of 150 µL injections, the wall thickness was increased by 0.5 mm (Figure 
13c).  The LV wall away from the injections, and the longitudinal dimensions, were 
unaltered relative to the control case.  The myofiber orientation was assigned to 
vary linearly from epicardium to endocardium using the angle of -37 degrees to 83 
degrees, respectively [37]. A pressure of 10 mmHg was assigned as a boundary 
condition on the endocardial surface in each of the FE models, in order to simulate 
end-diastole.  
 
4.2.2 Material response 
The material response of the myocardium was represented using a nearly 
incompressible, transversely isotropic, hyperelastic constitutive law, which was 
defined in Eq1. The diastolic material parameters were assigned to be C=0.51 kPa, 
𝑏𝑓 =22.84, 𝑏𝑡 =3.45, and 𝑏𝑓𝑠 =12 [51], while the bulk modulus was 𝜅 = 1e10
3 kPa.  
The material response of the hydrogel injections was represented using Eq 3. 
The material parameters for Young’s modulus (E) were assigned in a range 
between 0.1 kPa to 100 kPa, while the Poison ratio (𝜈) was assigned a value of 
0.499. The range for Young’s modulus was based on measurements by Rodell et 
al. [24], where two formulations with a modulus of 0.8 kPa and 41 kPa were 
injected into an ovine model of MI.  
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4.3 Results 
End-diastolic myofiber stress was assessed along the transmural direction, in 
between injections, for the different stiffness cases. Figure 13a shows that when 
the injection stiffness is 0.1 kPa the transmural distribution of stress is nearly 
unchanged compared to the untreated control. For a hydrogel stiffness of 25 kPa, 
the 150 µL injection reduced the myofiber stress by roughly 18.9% at the 
epicardium, 0% at mid-myocardium, and 21.6% at endocardium compared to the 
control (Figure 14b). While, the 300 µL injection reduced the myofiber stress by 
roughly 31% at the epicardium, 10.6% at the mid-myocardium, and 34.7% at the 
endocardium compared to the control (Figure 14b). For a hydrogel stiffness of 100 
kPa, the 150 µL injection reduced the myofiber stress by roughly 39.2% at the 
epicardium, 18.3% at mid-myocardium, and 38.7% at the endocardium compared 
to the control (Figure 14c). While, the 300 µL injection reduced the myofiber stress 
by roughly 56.8% at the epicardium, 36.5% at the mid-myocardium, and 55.2% at 
the endocardium compared to the control (Figure 14c).  
Additionally, the average myofiber stress in the myocardium surrounding the 
150 µL and 300 µL injections, using different hydrogel stiffness values, is shown 
in Figure 15. When the injection stiffness is increased, the myofiber stress was 
decreased. It should be noted that the influence of stiffness begins to level off after 
50 kPa. Figure 16 shows the average wall thickness as a function of injection 
stiffness. When the injection stiffness increased, the wall thickness was increased. 
The average wall thickness at end-diastole for the control was approximately 1cm, 
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while the thickness for the 150 µL injection with 25 kPa stiffness was 1.1cm and 
300 µL was 1.2cm. For the case of 150 µL injection with 100 kPa stiffness, the 
thickness was 1.2cm, while 300 µL was 1.3cm. This is primarily driven by the fact 
that the stiffer injections maintained their original shape during deformation, which 
allows the LV wall to remain thick (Figure 17c and 17f). On the other hand, it can 
be seen that the 0.1 kPa injections effectively collapse in the transmural direction 
as the LV wall is loaded by the pressure on the endocardium (Figure 17a and 17d). 
Figure 17 also shows the distribution of end-diastolic myofiber stress throughout 
the LV wall around the 150 µL injections (Figure 17 a-c) and 300 µL injections 
(Figure 17 d-f), with stiffness values of 0.1 kPa, 25 kPa and 100 kPa, respectively. 
It is clear that the myofiber stress showed a greater reduction around the hydrogel 
injection region when the volume was larger and the stiffness was higher.  
 
4.4 Discussion 
The goal of the current study was to assess the effect of different attributes that 
can be tuned for hydrogel injections. More specifically, this work utilized a 
combination of previously measured MRI data and FE modeling to investigate how 
injection stiffness and volume influence myocardial wall stress and wall thickness. 
The modeling results show a clear reduction of myofiber stress based on the higher 
hydrogel injection volume. Additionally, by turning the stiffness of the hydrogel, 
greater reductions in stress can be achieved. The current results indicated that 
stiffer hydrogel injections could reduce myofiber stress further. These 
improvements appear to taper after a stiffness of 50 kPa.  
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Previous studies have used FE modeling to assess the influence of biomaterial 
injections on LV function and wall stress. Kichula et al. [51] examined the effects 
of a single hydrogel formulation, which diffused between the tissue, and a single 
injection volume on LV wall stress. It was found that the injections increased the 
effective stiffness of the tissue and decreased stress in the wall.  Two other studies 
examined the effects of varying the volume of the injections on wall stress and LV 
ejection fraction, but did not examine the effects of injection stiffness. Lee et al. 
[52] used a patient-specific FE model to show that increasing the injection volume 
decreased both the end-diastolic and end-systolic stress in the myocardium. Wise 
et al. [53] used an animal-specific FE model of a rat heart to investigate a wide 
range of injection volumes in a model of MI. Interestingly, it was found that the 
beneficial effects of the injection began to diminish once the volume fraction of the 
injection exceeded 50% of the MI region. It should be noted that the volume fraction 
of hydrogel injection to treated myocardium in the current study was less than 15%. 
Also, the results of the current study were consistent with these previous studies, 
in terms of decreasing myofiber stress with increased injection volume. However, 
the current study showed the additional benefit of tuning the injection stiffness to 
reduce stress. 
In addition to FE modeling studies, several experimental studies with large 
animal models have been conducted. Ifkovits et al. found that stiffer hydrogel 
injections led to a reduction in adverse remodeling in the MI region, i.e., the MI 
region was smaller in animals treated with stiffer hydrogels, compared with the 
control infarct group [45].  In work done by Plotkin et al., it was shown that 
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hydrogels with the highest stiffness exhibited the best rescue of heart function [54], 
in terms of ejection fraction. Also, in another previous experiment study, it was 
shown that the higher stiffness hydrogel injection improved the ejection fraction 
after 8 weeks but not the lower stiffness hydrogel injection; and LVEDV measured 
using the higher stiffness hydrogel was smaller than the lower stiffness hydrogel 
[24]. All of these experimental studies showed greater benefit with a higher 
stiffness hydrogel, in terms of better LV geometry and function. This is consistent 
with the current FE modeling results, which indicate that the higher stiffness 
hydrogel injections are more beneficial. Additionally, previous injectable 
biomaterial studies have demonstrated that injections can increase LV wall 
thickness and the effective stiffness of the infarct region [45, 46, 50, 55-57]. This 
is also consistent with the current results, in which a higher injection stiffness led 
to increased wall thickness due to better retention of injection shape.  
 
4.5 Conclusion  
In the current work, FE modeling was used to predict how the LV wall thickness 
and myofiber stress change as a function of different hydrogel characteristics. This 
approach could be used as a tool for developing tunable hydrogel injections and 
predicting stress reduction and heart function post-MI. In the future, this method 
will be used to examine more optimal injectable biomaterial properties, which 
would be valuable clinical treatments for treat myocardial infarction.  
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Table 6 Ellipsoidal dimensions of the 150µL hydrogel injection and 300µL 
hydrogel injection, based on MRI data. 
 150 µL 300µL 
a 5.50 mm 6.60 mm 
b 3.15 mm 3.94 mm 
c 2.40 mm 2.73 mm 
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Figure 10 End-diastolic myofiber stress (kPa) distribution for an LV with (A) 
GH hydrogel injections and (B) DC hydrogel injections. Note that only a 
quarter of the model is shown in order to visualize the distribution within the 
myocardium. (C) Transmural fiber stress distributions for three cases [24].  
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Figure 11 Reconstruction of hydrogel geometry based on MRI data of 
injections embedded in myocardial wall. Note that the shape is 
approximately ellipsoidal [24]. 
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Figure 12 Hydrogel injections are well retained and can be approximated as 
an ellipsoid with characteristic dimensions a, b, and c. 
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(a)               
 (b) (c)  
Figure 13 (a) FE model of an ovine LV with 16 150 µL hydrogel injections. (b) 
Short axis view of the LV wall with 150 µL hydrogel injections. (c) Short axis 
view of the LV wall with 300 µL hydrogel injections. 
 
 
 
 
 
 
 
46 
 
 
 
 
 
Figure 14 (a-c) End-diastolic transmural distribution of myofiber stress using 
stiffness 0.1kPa, 25kPa and 100kPa hydrogel injection between 150µL 
injection and 300µL injection. 
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Figure 15 Average end-diastolic myofiber stress surrounding the injection 
as a function of injection stiffness and volume. 
 
Figure 16 End-diastolic myocardial wall thickness in the injection region as 
a function of injection stiffness and volume. 
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Figure 17 (a-c) The LV myofiber stress distribution around 150µL injections 
and (d-f) 300µL injections with stiffness values of 0.1kPa, 25kPa and 100kPa. 
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 Effects of Hydrogel Injection on Borderzone Contractility Post 
Myocardial Infarction 
 
5.1 Introduction  
Early infarct expansion or stretching has been associated with poor long-
term prognosis [13-15] and has been identified as the mechanical phenomenon 
that initiates and sustains the process of adverse post-MI LV remodeling that leads 
to heart failure [16-21]. Infarct expansion causes abnormal stress distribution in 
myocardial regions within and outside the MI, especially in the adjacent normally 
perfused borderzone (BZ) region. With time, increased regional stress is the 
impetus for maladaptive biologic processes, such as matrix metalloproteinase 
activation, that inherently alter the contractile properties of normally perfused 
myocardium [22]. Once initiated, these maladaptive processes lead to a heart 
failure phenotype that is difficult to reverse by medical or surgical means. 
It has been demonstrated that externally affixed ventricular restraint early 
after MI reduces infarct expansion, moderates regional stress distribution, 
improves BZ contractile function and, most importantly, limits long-term global LV 
remodeling in large-animal MI models [21, 58-61]. Although these studies have 
established the prevention of early infarct expansion as a potentially important 
therapeutic goal, it is unlikely that the surgical placement of restraining devices 
early after MI will gain widespread acceptance and application.  As a result, there 
has been extensive experimental work to study the effect of injecting 
percutaneously deliverable biomaterials into the infarct to limit global LV 
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remodeling [24, 62-64]. While our results have demonstrated improvement in 
remodeling, the effect of these materials on regional myocardial stress distribution 
and BZ contractile function has not been fully established. In this study, the 
approach was to employ a state-of-the art MRI-based finite element (FE) model 
that employs subject-specific LV geometry to assess the effect of early post-MI 
infarct delivery of a novel shear-thinning biomaterial system on regional post-MI 
contractile function and regional myocardial stress distribution at 8 weeks after MI 
in an ovine infarct model. 
 
5.2 Materials and Method 
5.2.1 Infarct model 
The data examined in the current study were collected in the course of a 
preceding study by Rodell et al [24] wherein protocols complied with the University 
of Pennsylvania’s Institutional Animal Care and Use Committee and animal care 
was in agreement with the National Institute of Health’s guidelines for the care and 
use of laboratory animals (NIH Publication 85-23, revised 1996). In brief, Dorset 
sheep (adult male, 45kg) underwent left thoracotomy to expose the heart. 
Posterolateral infarction was produced by suture ligation of selective obtuse 
marginal branches, resulting in infarcts comprising approximately 20% of the left 
ventricle. Sixteen injections (0.3 mL each) of saline (MI control, n=6) or dual-
crosslinking hydrogels (DC treatment, n=6) were performed within the infarcted 
region. DC hydrogels were prepared by separate modification of hyaluronic acid 
(HA) by both adamantane and thiols (Ad-HA-SH) or β-cyclodextrin and 
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methacrylates (CD-MeHA), with injectable hydrogels formed by their combination 
at a pH of 5 under sterile conditions as previously reported [24, 65]. 
5.2.2 Magnetic resonance (MR) imaging and analysis 
At 8 weeks post-infarction, MR image acquisition was performed (3T 
MAGNETOM Trio; Siemens; Malvern, PA) under maintained anesthesia (1-2% 
isoflurane) with cardiac gating using LV placement of a pressure transducer (Millar 
Instruments; Houston, TX), with magnetic tagging triggered at onset of systole. 
Recorded pressures were later used to determine loading in the model. 3D 
SPAMM was performed to enable generation of animal-specific LV geometry and 
determination of corresponding tissue displacement fields (field of view = 260 mm 
× 260 mm, acquisition matrix = 256 × 128, pixel size = 1.015 mm × 1.015 mm, 
repetition time = 34.44 ms, tag spacing = 6 mm, bandwidth = 331 Hz/pixel, slice 
thickness = 2 mm, averages = 4) [66]. Late-gadolinium enhanced (LGE) images 
were acquired 15 minutes following bolus administration of 0.1 mmol/kg 
gadobenate dimeglumine (MultiHance; Bracco Diagnostics; Cranbury, NJ) to 
confirm designation of the infarct region (field of view = 218 x 350 mm, acquisition 
matrix = 256 x 160, pixel size = 1.37x1.37 mm, repetition time = 5.50 ms, echo 
time = 2.42 ms, BW 244 Hz/pixel, slice thickness = 4 mm, averages = 2).  
Both epicardial and endocardial contours of the LV were generated (ImageJ; 
Bethesda, MD) from 3D SPAMM images at onset of systole to enable strain 
calculation by application of optical flow methods [66]. Contours were similarly 
generated at early diastole to generate the animal-specific reference geometry, 
including isolation of the endocardial and epicardial segments of the infarct region, 
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which was aided by synchronization with LGE images. Endocardial contours were 
used to determine the end-systolic (ESV) and end-diastolic (EDV) LV volumes.  
 
5.2.3 Finite Element modeling 
Finite element models were created based on each animal-specific LV 
geometry at early diastole. This configuration was chosen because the stress in 
the LV is at a minimum. The geometry of LV wall was based on experimental 
measurements from MRI. The infarct region was defined base on the LGE imaging 
discussed previously. The BZ region was approximated as a 20-degree sector 
which transitions from the infarct region to the remote region [67] (Figure 18).  
Each animal-specific LV FE mesh (MI, n=6; DC, n=6) was produced using 
tri-linear hexahedral brick elements, which were fit to 3D geometric surfaces that 
were generated from the endocardial and epicardial contours (TrueGrid; XYZ 
Scientific, Inc., Livermore, CA). The myofiber orientation in the remote, BZ, and 
infarct regions were assigned from epicardium to endocardium using the angles of 
-27 degrees to 88 degrees [48], -20 degree to 70 degree [68], and -5 degree to 26 
degree [48] respectively. For the DC cases, the infarct region was modified to 
include a pattern of hydrogel injections embedded within the wall (Figure 19(b)). 
The pattern and volume were approximated from MR images of a representative 
in-vivo injection (Figure 19(a)). It should be noted that the MRI reconstruction, 
shown in Figure 19(a), was only conducted on a single animal. Therefore, the 
injection pattern in each of the six DC cases was approximated from this 
distribution.  Since each injection was 0.3 ml, the total amount of volume added to 
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the infarct region was 4.8 ml. The endocardial wall of each MI and DC LV model 
was loaded with a pressure boundary condition, based on the experimentally 
measured values from the pressure transducer. Boundary conditions were 
implemented at the base of the LV to fully constrain displacement on the epicardial-
basal edge, while allowing the remaining basal nodes to move in the 
circumferential-radial plane.  
 
5.3 Material response  
The material response of the passive myocardium was represented in Eq1. 
The diastolic animal-specific material parameters, 𝐶 in the remote region and 𝐶_𝐼 
in the infarct region were optimized to match the corresponding EDV from MRI in 
each animal. Based on a previous study, the passive material parameters in the 
exponential function were assigned differently in the remote region (𝑏𝑓, 𝑏𝑡, 𝑏𝑓𝑠) and 
the infarct region (𝑏𝑓_𝐼, 𝑏𝑡_𝐼, 𝑏𝑓𝑠_𝐼) for the MI case and DC case (MI: 𝑏𝑓=37.67, 
𝑏𝑡 =17.39, 𝑏𝑓𝑠 =23.12, 𝑏𝑓_𝐼=22.67, 𝑏𝑡_𝐼=19, 𝑏𝑓𝑠_𝐼=18.12, DC: 𝑏𝑓 =22.84, 𝑏𝑡 =3.46, 
𝑏𝑓𝑠=12, 𝑏𝑓_𝐼=15.28, 𝑏𝑡_𝐼=8.32, 𝑏𝑓𝑠_𝐼=25.27) [48]. Note that the passive material 
parameters chosen in the BZ region were the same as the remote regions at 8 
weeks post-infarction. The bulk modulus was assigned as 𝜅 = 1.0 MPa.   
The material response of the hydrogel injections was represented in Eq 3. 
The material parameters for Young’s modulus (E) were assigned based on the 
experimental measurements of the DC hydrogels at 8 weeks (E=4.5 kPa, 
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determined in previous study [17]), while the Poison ratio (𝜈) was assigned a value 
of 0.499 (due to near incompressibility).  
 Systolic stress was modeled using Eq 4. The systolic material parameter 
associated with the maximum isometric tension, within the remote (𝑇max _𝑅), and 
BZ (𝑇max _𝐵) region, was calculated using numerical optimization. The parameter in 
the infarct region (𝑇max _𝐼 ) was assigned to be zero, which was confirmed in 
previous work [69]. The initial search range in the optimization was set between 
50 kPa and 400 kPa for 𝑇max _𝑅 and between 10 kPa and 300 kPa for 𝑇max _𝐵, while 
𝑇max _𝐼 = 0. A cross-fiber in-plane stress component equivalent to 40% of the fiber 
component was added based on previous studies of LV contraction [34].  
 
5.4 Optimization  
Each FE simulation was conducted in two phases, where the first phase 
represented passive diastolic filling and the second phase represented active 
systolic contraction to end-systole (LS-DYNA, Livermore Software Technology 
Corporation, Livermore, CA). The genetic algorithm (GA) was used to minimize the 
objective function, which was taken to be the sum of the squared error (SE) 
between the experimentally measured systolic strain data from MRI and FE 
predicted results, and was defined as 
𝑆𝐸 = ∑ ∑  𝑤𝑛(𝐸𝑖𝑗,𝑛 − ?̅?𝑖𝑗,𝑛)
2
𝑖,𝑗=1,2,3
𝑁
𝑛=1 + (
𝑉−?̅?
?̅?
)
2
                                                  (Eq 7) 
 
55 
where 𝑛 is the strain point within the myocardium, 𝑁 is the total number of strain 
points, 𝐸𝑖𝑗,𝑛 and 𝑉 are the FE predicted end-systolic strain and LV cavity volume, 
respectively. The over bar variables represent in-vivo measured values.  Since 
there were fewer strain points measured in the BZ region compared to the remote 
region, the weight for the SE in the BZ was set to 3 while the rest were set to 1.  
 
5.5 Statistical analysis 
Data is presented as mean ± standard error (SEM) of the mean. For 𝑇𝑚𝑎𝑥 
and ES fiber stress, comparison between groups (MI, DC) was performed by two-
tailed student’s t-test with significant determined at p < 0.05. For the MI model and 
DC model, statistical significance in different regions was determined by one-way 
ANOVA. Bonferroni test was used to account for multiple comparisons procedures 
with α=0.05.  
 
5.6 Results 
The average diastolic animal-specific material parameters, 𝐶 in the remote 
region and 𝐶_𝐼 in the infarct region, were determined such that the model EDV 
matched the corresponding EDV from MRI. The values were found to be 
𝐶=0.15±0.06 kPa and 𝐶_𝐼=9.43±4.45 kPa for the MI cases and 𝐶=0.893±0.24 and 
𝐶_𝐼=23.67±4.55 for the DC cases, respectively. The contractility parameter 𝑇max 
was determined from optimization of all animal-specific models. For the MI case, 
the parameter 𝑇max _𝑅 =205.29±40.98 kPa and 𝑇max _𝐵 =49.31±15.56 kPa. This 
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represents a 76% reduction in contractile force in the BZ of the untreated MI 
controls, relative to the remote region. For the DC case, 𝑇max _𝑅=163.66±25.23 kPa 
and 𝑇max _𝐵=122.13±26.82 kPa. This represents only a 25% reduction in contractile 
force in the BZ of treated animals, relative to the remote region. In terms of the fit 
achieved during the optimization, the average SE value for the MI case was 
25.9±2.3 and for the DC case was 22.8±3.1. 
In the remote region, the difference in contractile function between the DC 
and MI case was not associated with any statistical significance (p=0.407) (Figure 
20a). In contrast, the contractility in the BZ region predicted in the DC case was 
higher and significantly different from the MI case (p*=0.0408) (Figure 20a). 
Additionally, in the MI case, the contractile function was significantly different 
between the remote region and BZ region (p*=0.005) (Figure 20a). However, the 
tissue contractile function in the DC case was similar when comparing between 
the remote region and BZ region, i.e., no statistical significance (p=0.286) (Figure 
20a). These results indicate that the BZ tissue in the DC case has higher 
contractility compared to the MI case.  
The average wall thickness within the infarct region at end-diastole for the 
MI and DC cases were 0.5±0.02 cm and 1.05±0.06 cm, respectively. In the BZ 
region, the average wall thickness was measured to be 0.64±0.01 cm and 
0.86±0.04 cm for MI and DC cases, respectively. In the remote region, the average 
wall thickness in the MI case was 0.975±0.05 cm while in the DC case was 
0.985±0.05 cm. This indicated that the DC hydrogel treatment reduced wall 
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thinning at 8 weeks post-infarction and a significant difference was observed 
between the DC and MI cases [24].  
The average ES fiber stress in the infarct region of the DC case was 
significantly reduced by 40% relative to the MI case (MI: 47.28±6.11 kPa, DC: 
28.52±3.83 kPa; p*=0.0264). The averages ES fiber stress of the DC case in the 
BZ region was also significantly reduced by 33% relative to the MI case (MI: 
28.96±1.94 kPa, DC: 19.36±1.71 kPa; p*=0.0041). In the remote region, the ES 
fiber stress shows a significant reduction of 34% compared to the MI case (MI: 
22.08±1.46 kPa, DC: 14.59±2.07 kPa; p*=0.0144) (Figure 20b). The end-systolic 
fiber stress distribution in different regions of the mid-ventricle wall are shown for 
a representative DC hydrogel injection case (Figure 21a) and a representative 
control MI case (Figure 21c). Figures 20b and 20d indicate the different material 
regions for evaluating the fiber stress distribution, and also show the differences in 
wall thickness at end-systole. 
 
5.7 Discussion  
Despite the established efficacy and widespread availability of reperfusion 
therapy, myocardial infarction resulting from coronary artery disease and 
subsequent adverse LV remodeling remains a leading cause of heart failure [70]. 
In the majority of acute MI patients, the LV function is initially preserved and only 
after months or years do symptoms of heart failure develop. The severity of the LV 
response to MI (i.e. LV remodeling) is determined by the size, location and 
transmurality of the infarct. Initially this response is largely mechanical, but with 
 
58 
time these physical phenomena initiate a complex cascade of progressive 
maladaptive biologic sequelae that permanently compromise the contractile 
function of the perfused myocardium outside of the infarcted region [17].  
Infarct expansion (i.e. stretching) early after MI has long been recognized 
as a clinical risk factor for adverse LV remodeling and the development of heart 
failure symptoms. It has been demonstrated that early infarct expansion is 
associated with increased mechanical stress in the infarct and adjacent BZ region, 
which results in progressive loss of contractile function in perfused myocardium 
adjacent to the infarct. It has also been shown that this dysfunctional BZ becomes 
more hypocontractile and progresses to involve additional perfused myocardium 
as remodeling continues and heart failure develops [17]. 
In an extensive series of preclinical large animal studies, it was 
demonstrated that infarct restraint with mesh wrapping devices in the early post MI 
period normalizes regional LV stress, preserves BZ contractility, and limits global 
LV remodeling [22, 58-61]. This work strongly supports the idea that the prevention 
of infarct expansion is an important therapeutic goal intended to limit MI-induced 
LV remodeling. However, the use of external restraint devices in the form of mesh 
jackets and patches is never likely to achieve widespread clinical application 
because of the invasive surgical procedures that would be required in the early 
post-MI period to place them. Given this clinical reality, researchers have begun to 
explore and develop the use of hydrogel biomaterials to modify infarct material 
characteristics to limit or prevent progressive infarct expansion [24, 62-64]. The 
use of such materials holds the potential for percutaneous, catheter-based 
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approaches for beneficially altering the post-MI LV remodeling process. The novel 
shear-thinning biomaterial system tested in this study is an emerging candidate for 
translation into patents because it can be administered through long, narrow 
catheters but at the same time can be engineered to the appropriate stiffness for 
optimally limiting infarct expansion [65]. 
The efficacy of this biomaterial system on post MI LV remodeling has been 
previously reported [24].  However, its effect on regional myocardial stress 
distribution and BZ contractile function had not yet been assessed. To better 
elucidate the biomechanical mechanism by which this hydrogel system affects the 
remodeling process, the current study employed a state-of-the-art MRI-based finite 
element model that employs subject-specific LV geometry to assess the effect on 
regional post-MI contractile function and regional myocardial stress distribution at 
8 weeks after MI in an ovine infarct model.  
Utilizing this approach, it was found that contractility in the BZ of animals 
treated with hydrogel injection was significantly higher than untreated controls, 
indicating that function is better retained due to treatment. This result shows strong 
agreement with purely MRI-based studies, which found that ES principal strains 
were higher in animals treated with hydrogel injections (implying stronger 
contraction) [48]. It was also found that the passive stiffness of the treated infarct 
region was much greater than the untreated control. Additionally, the wall thickness 
in the infarct and BZ regions were significantly higher in the treated animals. Both 
of these factors are likely contributors to the fact that end-systolic fiber stress was 
greatly reduced in the BZ of treated animals. 
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Treatment with hydrogel injection significantly improved BZ function and 
reduced LV remodeling, via altered MI properties. These changes are linked to a 
reduction in the ES fiber stress experienced in the BZ myocardium surrounding the 
infarct. The current results, in conjunction with those reported previously, imply that 
the novel shear-thinning hydrogel system used in this study should be a viable 
therapy for mitigating adverse LV remodeling after MI. 
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(a) (b)  
 
Figure 18 (a) Animal-specific FE model. The red elements represent the 
remote region, green elements are BZ region, and blue elements are the 
infarct region. (b) Short axis cross-section view of the animal-specific FE 
model near mid-ventricle.  
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(a)   (b)   
 
Figure 19 (a) MRI reconstruction of retained DC hydrogel (red) within the 
infarct region (purple) in vivo [24]. (b) DC FE model with approximated 
hydrogel injection pattern (brown) within the infarct. 
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(a)  
(b)  
Figure 20 (a) Comparison of T_max distribution between MI case and DC 
case in remote region and BZ region, respectively. (b) Comparison of end-
systolic (ES) fiber stress between MI case and DC case in the infarct, BZ, and 
remote regions, respectively. 
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(a)   (b)       
                (c) (d)  
 
Figure 21 (a) End-systolic fiber stress distribution in cross section view of 
an animal-specific MI FE model near mid-ventricle. (b) Cross section view of 
the MI FE model at end-systole in same location. (c) End-systolic fiber stress 
distribution in cross section. 
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 Conclusion  
 
To sum up this dissertation, Chapter 3 utilized MRI data and computational 
modeling to estimate the in vivo contractile forces generated in three different 
transmural regions of healthy pig ventricles. The primary conclusion is that a FE 
model with non-uniform contractility distribution is more representative of the 
deformation that occurs in-vivo. Chapter 4 evaluated the sensitivity effect of 
hydrogel stiffness for treating myocardial infarction compared to control injection 
case. This study is a continuation of a previous study [24], in which this treatment 
was beneficial to prevent dilation of the left ventricle over the time of the remodeling 
process. The current study employed a combination of experimental data and FE 
modeling to correlate how injection stiffness and volume influence myocardial wall 
stress and wall thickness.  The conclusion was that by tuning the stiffness of 
hydrogel, greater reductions in fiber stress can be achieved, but these 
improvements begin to taper after a stiffness of 50 kPa. Chapter 5 expanded on 
the baseline work conducted in Chapter 3 by assessing the contractility in MI 
control and DC hydrogel injection treated animals. In this study, contractility in the 
BZ of animals treated with hydrogel injection was significantly higher than 
untreated animals. Additionally, the wall thickness in the infarct and BZ were found 
to be significantly higher in the treated animals. These results imply that injectable 
hydrogels could be a viable therapy for maintaining LV function post myocardial 
infarction 
 .
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